510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

The Helena V8 Immunodisplacement Kit

K111369510(k) TraditionalCleared Jun 26, 2012407-day reviewClass II21 CFR 866.5510Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Helena Laboratories Uk, Ltd. · CFF Immunoelectrophoretic, Immunoglobulins, (G, A, M)

Cleared on Jun 26, 2012 after a 407-day review. FDA’s file for it is a 510(k) statement, which names no predicate. It has been recalled once.

Decided
Jun 26, 2012
Review
407 days
Class
Class II
Product code
CFF
Recalls
1
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K111369Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CFF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CFF device

  1. #1 K203184 HYDRASHIFT 2/4 isatuximabscore 2.3 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 6, 2022Class IIZ-1244-2022Unknown/Undetermined by firmDue to microbial growth causing interference with interpretation.

No ancestor or descendant has a Class I recall.

How does its category compare?

All CFF devices

CFF Immunoelectrophoretic, Immunoglobulins, (G, A, M): FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · CFF

1in 2021

2009: 22011: 12012: 22015: 12016: 12018: 12019: 22021: 1
2007high 2 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CFF

Too few CFF 510(k)s in any year since 2007 to give a median.

Recalls per year · CFF

1in 2022

2017: 12022: 1
2007high 1 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CFF

1in 2021

2012: 12021: 1
2007high 1 (2012) · low 0 (2007)2025

MAUDE reports naming product code CFF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20092—00
20100—00
20111—00
20122—01
20130—00
20140—00
20151—00
20161—00
20170—10
20181—00
20192—00
20200—00
20211—01
20220—10
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Helena V8 Immunodisplacement Kit is designed for the detection and the characterization of monoclonal proteins (immunoglobulin's lgG, IgA, 1gM, kappa (bound) and lambda (bound) light chains), in human serum with the Helena V8 Capillary Electrophoresis System. It is used in conjunction with the Helena V8 Serum Protein SPE Kit designed for serum protein separation into 6 major fractions in alkaline buffer. The electrophoretograms of separated proteins…

Read the full statement (109 words)

The Helena V8 Immunodisplacement Kit is designed for the detection and the characterization of monoclonal proteins (immunoglobulin's lgG, IgA, 1gM, kappa (bound) and lambda (bound) light chains), in human serum with the Helena V8 Capillary Electrophoresis System. It is used in conjunction with the Helena V8 Serum Protein SPE Kit designed for serum protein separation into 6 major fractions in alkaline buffer. The electrophoretograms of separated proteins mixed with individual specific antisera. are evaluated visually to detect the presence of specific reactions with the suspect monoclonal proteins. The test results are to be used in conjunction with clinical findings and other laboratory tests.

For In Vitro Diagnostic Use Only.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K111369: The Helena V8 Immunodisplacement Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K111369

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026